ArticleJournal of vascular surgery2017
Improved outcomes and value in staged hybrid extent II thoracoabdominal aortic aneurysm repair.
Article in Journal of vascular surgery, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 12 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
12 citing papers in PubMed, 44 citations in OpenAlex.
- Complete Occlusion of All Three Mesenteric Arteries with Collateral Supply via Bilateral Internal Mammary Arteries.Cardiovascular and interventional radiology · 2026Article
- Hybrid repair of the complex celiac artery aneurysm.International journal of surgery case reports · 2025Article
- A Computational Study on Renal Artery Anatomy in Patients Treated with Fenestrated or Branched Endovascular Aneurysm Repair.Bioengineering (Basel, Switzerland) · 2025Article
- Complex staged hybrid repair of extent II thoracoabdominal aortic aneurysm secondary to type A aortic dissection.Journal of vascular surgery cases and innovative techniques · 2025Article
- Spinal cord protection in open and endovascular aortic surgery: current strategies, controversies and future directions.Frontiers in cardiovascular medicine · 2025Review
- Open, closed or a bit of both: a systematic review and meta-analysis of staged thoraco-abdominal aortic aneurysm repair.Annals of cardiothoracic surgery · 2023Article
- Spinal cord protection for thoracoabdominal aortic aneurysm repair: from bench to bedside.Annals of cardiothoracic surgery · 2023Review
- Comparison of efficiency and safety of open surgery, hybrid surgery and endovascular repair for the treatment of thoracoabdominal aneurysms: a systemic review and network meta-analysis.Frontiers in cardiovascular medicine · 2023Review
- Single-staged hybrid repair of extent II thoracoabdominal aortic aneurysm with infrarenal abdominal aortic occlusion.Journal of vascular surgery cases and innovative techniques · 2022Article
- Preventing spinal cord injury following thoracoabdominal aortic aneurysm repair: The battle to eliminate paraplegia.JTCVS techniques · 2021Article
- Endovascular Treatment of Various Aortic Pathologies: Review of the Latest Data and Technologies.The International journal of angiology : official publication of the International College of Angiology, Inc · 2018Review
- Hybrid thoracoabdominal aortic aneurysm repair: is the future here?Journal of visualized surgery · 2018Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors at 2 institutions in 1 country.
Funding
Abstract
objectiveComplex Crawford extent II thoracoabdominal aortic aneurysms (TAAAs) can be treated in a hybrid manner with proximal thoracic endovascular aneurysm repair, followed by staged distal open thoracoabdominal repair. This study evaluated the outcomes and health care-associated value of this new method compared with traditional open repair over 10 years.
methodsA prospectively collected database was used to identify all patients with an extent II TAAA undergoing repair at a single institution between 2005 and 2015. Patient characteristics, postoperative outcomes, and incidence of major adverse events (MAEs; renal failure, spinal cord ischemia, death) were compared. After adjusting for time since surgery, value was analyzed looking at quality (1/MAE) divided by cost (total health system cost). This was multiplied by a constant to set the value of open TAAA repair to 100.
resultsA total of 113 consecutive patients underwent extent II TAAA repairs, of whom 25 (22.1%) had a staged hybrid approach with a median of 129 days between procedures. No baseline differences in demographic or comorbidity variables existed between groups (P > .05). The hybrid group had shorter operative time (255 vs 306 minutes; P = .01), shorter postoperative length of stay (10.1 vs 13.3 days; P = .02), and reduced blood loss (1300 vs 2600 mL; P = .01) at the time of open operation. Despite higher rates of acute kidney injury in the hybrid group (76.0% vs 51.1%; P = .03), there was no difference in renal failure (8.0% vs 4.5%; P = .84). The incidence of MAEs was lower in the staged hybrid group (20.0% vs 48.9%; P = .01), without a difference in hospital mortality (4.0% vs 3.4%; P = .89). Median total cost was higher in the hybrid group ($112,920 vs $72,037; P = .003). Value was improved in the hybrid group by 56% using mean cost and 178% by median cost.
conclusionsThe 20% MAE rate associated with staged hybrid repair of extent II TAAA was significantly decreased compared with open repair, with a relative reduction of >50%. Despite higher total hospital costs, staged hybrid repair had 56% to 178% higher health care-related value compared with standard open repair. In an era of increasing focus on costs and quality, staged hybrid repair of extensive TAAAs is associated with fewer complications than open TAAA repair, resulting in a good value investment from a resource utilization perspective.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.